2024-09-21 - Analysis Report
## Pfizer Inc. (PFE) Stock Analysis Report

**Company Overview:** Pfizer Inc. is a global pharmaceutical company that researches, develops, manufactures, and markets drugs and vaccines.

**Performance Analysis:**

1. **Performance Comparison:** PFE has underperformed the S&P 500 (VOO) significantly. Its cumulative return is -10.62%, while the S&P 500 has returned 133.16%, resulting in a substantial gap of -143.78%. This puts PFE at the lowest position in the historical data range. 
2. **Price Movement:** 
    * Closing price: $29.76
    * 5-day Moving Average: $29.71
    * 20-day Moving Average: $29.11
    * 60-day Moving Average: $29.1
    * The price is currently above the 5-day and 20-day moving averages, indicating potential short-term momentum.
3. **Technical Indicators:**
    * RSI: 62.05 - This suggests that the stock is currently in overbought territory, indicating potential short-term downward pressure.
    * PPO: 0.37 -  This is a bullish signal, indicating potential upward momentum.
    * Delta_Previous_Relative_Divergence: -1.45 - This indicates a recent (20-day) decline in the relative strength of the stock compared to the S&P 500.
    * Expected_Return: 15.25% - This represents the potential expected return over a 5-10 year period, assuming current investment levels remain consistent.
4. **Recent Earnings and Outlook:** 

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |
| 2023-08-01 | 0.67 | 0.56 |

The most recent earnings report for the quarter ending July 30, 2024, shows that PFE exceeded expectations, with EPS of $0.6 compared to the expected $0.458. This indicates a positive performance.

**Overall Analysis:**

PFE's performance has lagged significantly behind the market. While recent earnings show positive results, the stock is currently overbought according to the RSI indicator. The price movement is positive, but the short-term relative strength indicator signals potential for downward pressure. Despite this, the PPO indicator is bullish, suggesting potential for further price appreciation. The long-term expected return is positive, indicating potential for growth.

**Recommendations:**

Investors should monitor the stock's performance closely, particularly the RSI and PPO indicators. Despite the recent positive earnings, the lagging performance and overbought nature of the stock warrant caution. The long-term growth potential suggests that holding the stock for an extended period might be beneficial, but investors should be mindful of potential short-term volatility. 
